Capricor Therapeutics Management
Management criteria checks 4/4
Capricor Therapeutics' El consejero delegado es Linda Marbán , nombrado en Jan 2010, tiene un mandato de 13.92 años. la remuneración anual total es $1.33M , compuesta por 15.7% salario y 84.3% primas, incluidas acciones y opciones de la empresa. posee directamente 0.64% de las acciones de la empresa, por valor de $716.96K . La antigüedad media del equipo directivo y del consejo de administración es de 11.8 años y 10.1 años respectivamente.
Key information
Linda Marbán
Chief executive officer
US$1.3m
Total compensation
| CEO salary percentage | 15.7% |
| CEO tenure | 14.3yrs |
| CEO ownership | 0.6% |
| Management average tenure | 12.1yrs |
| Board average tenure | 10.4yrs |
Recent management updates
Recent updates
Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) 25% Dip In Price Shows Sentiment Is Matching Revenues
Feb 03
Is Capricor Therapeutics (NASDAQ:CAPR) In A Good Position To Invest In Growth?
Dec 13Here's Why We're Not Too Worried About Capricor Therapeutics' (NASDAQ:CAPR) Cash Burn Situation
Aug 13A Look At The Fair Value Of Capricor Therapeutics, Inc. (NASDAQ:CAPR)
Nov 03Capricor Therapeutics GAAP EPS of -$0.29 misses by $0.03
Aug 10Companies Like Capricor Therapeutics (NASDAQ:CAPR) Are In A Position To Invest In Growth
Feb 01We Think Capricor Therapeutics (NASDAQ:CAPR) Can Afford To Drive Business Growth
Oct 14Capricor Therapeutics Announces Another 'Final' 12-Month P2 Duchenne Muscular Dystrophy Trial Result
Sep 25Capricor Therapeutics slumps 9% on $75M stock offering
Jun 21Capricor Therapeutics (NASDAQ:CAPR) Is In A Good Position To Deliver On Growth Plans
May 16When Will Capricor Therapeutics, Inc. (NASDAQ:CAPR) Turn A Profit?
Mar 13Capricor signs intellectual property license for COVID-19 serology test platform
Feb 01Capricor and Lonza tie up in DMD development
Jan 12Dosing underway in Capricor Therapeutics' mid-stage CAP-1002 study in COVID-19
Nov 24CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$22m |
| Sep 30 2023 | n/a | n/a | -US$29m |
| Jun 30 2023 | n/a | n/a | -US$29m |
| Mar 31 2023 | n/a | n/a | -US$29m |
| Dec 31 2022 | US$1m | US$210k | -US$29m |
| Sep 30 2022 | n/a | n/a | -US$27m |
| Jun 30 2022 | n/a | n/a | -US$25m |
| Mar 31 2022 | n/a | n/a | -US$23m |
| Dec 31 2021 | US$2m | US$200k | -US$20m |
| Sep 30 2021 | n/a | n/a | -US$18m |
| Jun 30 2021 | n/a | n/a | -US$18m |
| Mar 31 2021 | n/a | n/a | -US$17m |
| Dec 31 2020 | US$2m | US$150k | -US$14m |
| Sep 30 2020 | n/a | n/a | -US$11m |
| Jun 30 2020 | n/a | n/a | -US$9m |
| Mar 31 2020 | n/a | n/a | -US$7m |
| Dec 31 2019 | US$229k | US$157k | -US$8m |
| Sep 30 2019 | n/a | n/a | -US$9m |
| Jun 30 2019 | n/a | n/a | -US$12m |
| Mar 31 2019 | n/a | n/a | -US$14m |
| Dec 31 2018 | US$377k | US$233k | -US$15m |
| Sep 30 2018 | n/a | n/a | US$374k |
| Jun 30 2018 | n/a | n/a | US$2m |
| Mar 31 2018 | n/a | n/a | US$2m |
| Dec 31 2017 | US$602k | US$233k | US$2m |
Compensación vs. Mercado: La compensación total de Linda ($USD1.33M) es aproximadamente el promedio para empresas de tamaño similar en el mercado US ($USD1.49M).
Compensación vs. Ingresos: Lindaha sido coherente con los resultados de la empresa en el último año.
CEO
Linda Marbán (60 yo)
14.3yrs
Tenure
US$1,333,423
Compensation
Dr. Linda Marbán, Ph.D. Co-founded Capricor Therapeutics, Inc. (also known as Capricor, Inc). in 2005 and also has been its Chief Executive Officer since 2010 and serves as its President. Dr. Marbán has be...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board | 12.3yrs | US$821.76k | 0.42% $ 945.6k | |
| Co-Founder | 14.3yrs | US$1.33m | 0.63% $ 1.4m | |
| CFO & Corporate Treasurer | 6.3yrs | US$923.69k | 0.0076% $ 16.9k | |
| Executive VP | 12.1yrs | US$668.44k | 0.064% $ 142.2k | |
| Co-Founder & Chairman of Scientific Advisory Board | no data | no data | no data | |
| Chief Science Officer | no data | no data | no data | |
| Consultant | no data | no data | no data |
12.1yrs
Average Tenure
63.5yo
Average Age
Equipo directivo experimentado: CAPREl equipo directivo de la empresa es veterano y experimentado (11.8 años de antigüedad media).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board | 12.3yrs | US$821.76k | 0.42% $ 945.6k | |
| Co-Founder | 10.4yrs | US$1.33m | 0.63% $ 1.4m | |
| Co-Founder & Chairman of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 10.4yrs | US$175.43k | 0.034% $ 74.9k | |
| Independent Director | 10.4yrs | US$175.43k | 0.085% $ 190.5k | |
| Independent Director | 10.4yrs | US$233.91k | 0.12% $ 274.1k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
10.4yrs
Average Tenure
67yo
Average Age
Junta con experiencia: CAPRLos consejos de administración de la empresa son veteranos y experimentados ( 10.1 años de permanencia media en el cargo).